Search clinical trials for: Lonafarnib
Total 36 results
-
Pediatric Brain Tumor ConsortiumNational Cancer Institute (NCI)CompletedBrain and Central Nervous System TumorsUnited States
-
Merck Sharp & Dohme LLCTerminatedMetastases, Neoplasm | Carcinoma, Non-small-cell Lung
-
Merck Sharp & Dohme LLCTerminatedBreast Cancer | Gastric Cancer | Ovarian Cancer | Lung Cancer | Prostate Cancer
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)WithdrawnColorectal Cancer | Metastatic Cancer
-
European Organisation for Research and Treatment...UnknownBrain and Central Nervous System TumorsSwitzerland, France
-
M.D. Anderson Cancer CenterCompletedChronic Myelogenous LeukemiaUnited States
-
Boston Children's HospitalEnrolling by invitation
-
Eiger BioPharmaceuticalsApproved for marketing
-
M.D. Anderson Cancer CenterCompletedMyelogenous Leukemia, ChronicUnited States
-
Monica E. KleinmanSchering-PloughCompletedProgeria | Hutchinson-Gilford SyndromeUnited States
-
National Institute of Diabetes and Digestive and...Completed
-
George SledgeHoosier Cancer Research Network; Schering-PloughTerminated
-
European Organisation for Research and Treatment...CompletedBladder Cancer | Transitional Cell Cancer of the Renal Pelvis and Ureter | Urethral CancerNetherlands
-
M.D. Anderson Cancer CenterSchering-PloughCompletedCarcinoma, Squamous Cell | Cancer of Head and NeckUnited States
-
European Organisation for Research and Treatment...CompletedBreast CancerBelgium, Netherlands, France
-
Jonsson Comprehensive Cancer CenterWithdrawn
-
AGO Study GroupCompletedEpithelial Ovarian CancerGermany
-
Boston Children's HospitalMerck Sharp & Dohme LLC; Schering-Plough; Eiger BioPharmaceuticalsActive, not recruitingProgeriaUnited States
-
Merck Sharp & Dohme LLCTerminatedMyelodysplastic Syndromes | Leukemia, Myelomonocytic, Chronic | Myelodysplasia | Myelomonocytic
-
Eiger BioPharmaceuticalsHannover Medical SchoolCompletedChronic Delta Hepatitis
-
M.D. Anderson Cancer CenterCompletedGlioblastoma MultiformeUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedLymphoma | Unspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Emory UniversitySchering-Plough; Aventis PharmaceuticalsTerminatedSoft Tissue Sarcoma | Breast Cancer | Lung Cancer | Prostate Cancer | Colorectal CarcinomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Schering-PloughTerminated
-
Eiger BioPharmaceuticalsCompletedHepatitis Delta VirusUnited States, Belgium, Spain, Greece, Canada, Italy, Romania, Germany, Israel, Bulgaria, Taiwan, Turkey, Pakistan, Sweden, Ukraine, New Zealand, Russian Federation, United Kingdom, Moldova, Republic of, France, Mongolia, Switzerland
-
Eiger BioPharmaceuticalsCompleted
-
Eiger BioPharmaceuticalsAnkara UniversityCompletedChronic Hepatitis D InfectionTurkey
-
Soroka University Medical CenterEiger BioPharmaceuticalsActive, not recruitingHepatitis D, ChronicIsrael, New Zealand, Turkey
-
Boston Children's HospitalDana-Farber Cancer Institute; Brigham and Women's Hospital; Schering-PloughCompletedProgeria | Hutchinson-Gilford SyndromeUnited States
-
Merck Sharp & Dohme LLCCompleted
-
Eiger BioPharmaceuticalsWithdrawnChronic Delta Hepatitis
-
National Institute of Diabetes and Digestive and...Completed
-
Duke UniversitySchering-PloughCompletedPH I Addition of Farnesyl Transferase Inhibitor to Temozolomide for Pts w Gr 3 & 4 Malignant GliomasGlioblastoma | Gliosarcoma | Anaplastic AstrocytomaUnited States
-
National Institute of Diabetes and Digestive and...CompletedHepatitis D | Liver DiseaseUnited States
-
Aston UniversityUniversity of WorcesterCompleted
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingRecurrent Glioblastoma | Recurrent Gliosarcoma | Malignant Supratentorial NeoplasmUnited States